Troikaa Pharmaceuticals Ltd (CEO Mr. Ketan Rajnikant Patel, www.troikaa.com) plans to participate at KOREA PHARM 2013 that is being held at KINTEX Center from May 28th to the 31st.
Troikaa is one of the leading pharmaceutical companies of India which has acquired a reputation of being an innovative company, over the years.
The company holds unique patented technology platforms for intraoral, topical, parenteral, sustained release and topical drug delivery.
Dynapar QPS is the latest novel research product developed by the innovative R&D of Troikaa Pharmaceuticals. Dynapar QPS is a topical solution of 4% Diclofenac. It is manufactured by Original research QPS Technology. QPS stands for Quick Penetrating Solution which is a novel globally patented drug delivery platform providing quick & comprehensive penetration of the drug through the skin. Dynapar QPS is the first time ever formulation which has been backed by various clinical trials showing its superiority over diclofenac gels & aerosol sprays in terms of higher penetration & pain relief. It is available in a cobalt blue colored 30ml glass bottle with a metered dose spray for hands free application. Another variant is Dynapar QPS Plus having 2% Diclofenac with menthol & Methyl Salicylate.
KOREA PHARM 2013 is the only trade exhibition in Korea specialized in pharmaceutical industry. Hosted by KFDA, organized by KPMA, Kyungyon Exhibitor Corp, KOREA PHARM is becoming the most important industrial event of pharmaceutical field in Korea.
Link to KOREA PHARM 2013 SPECIAL NEWS PAGE